Physician profile
Anna Sall
NPI 1003545187
$1,241.23
in general payments reported to CMS, 2019-2025
11 companies · $426 in 2025
The $426 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $252 · 2024: $420 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $319.18 | 2023-2024 | Progrip, Interstim, Endurant Iis |
| Heron Therapeutics, INC. | $161.35 | 2022-2024 | Zynrelef |
| Stryker Corporation | $148.34 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mimedx Group, INC. | $121.03 | 2025 | |
| Organogenesis INC. | $106.91 | 2025 | Puraply Wound Matrix |
| Penumbra, INC. | $99.19 | 2023 | Indigo System |
| La Jolla Pharmaceutical Company | $94.50 | 2023 | Xerava |
| Conmed Corporation | $83.89 | 2022 | |
| Ethicon US, LLC | $49.35 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix |
| Cardiva Medical, INC. | $44.28 | 2023 | Cardiva Vascade 6/7f Vcs |
| Bard Peripheral Vascular, INC. | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.